Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
NCT ID: NCT02312037
Last Updated: 2019-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NO_LONGER_AVAILABLE
EXPANDED_ACCESS
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Contact: [email protected]
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia
NCT01869803
A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World
NCT04337138
Retrospective Analysis of the Outcome of Patients With Relapsed/Refractory Acute Myeloid Leukemia Included in a Patient Named Program of Gemtuzumab Ozogamicin/Mylotarg®
NCT03287128
Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant
NCT00044733
Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS
NCT02221310
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antibody Drug Conjugate Chemotherapeutic
Three Treatment Regimens:
1. Mylotarg \<=9 mg/m2 as a single agent on Day 1 \& 14 of a 28-day cycle for a total of two cycles
2. Mylotarg in combination with a recognized anthracycline and/or nucleoside-antagonist containing regimen
3. Mylotarg as monotherapy or in tested combinations with ATRA and/or arsenic trioxide for APL
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
OR
* Confirmed diagnosis of relapsed or refractory APL with persisting or rising leukemic burden (either by morphology, cytogenetic analysis or by molecular techniques), and no other comparable or satisfactory alternative therapy available.
* Documentation that malignant cells express CD33
4\) Age \>=3 months
5\) Adequate non-hematologic organ function
Exclusion Criteria
* Patients with a known history of VOD/SOS.
* Patients with a known hypersensitivity to Mylotarg or its parts: hP67.6 antibody, calicheamicin derivatives or other ingredients.
* Participation in other studies involving investigational drug(s) (Phases 1-4) during study participation.
3 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham/Children's of Alabama
Birmingham, Alabama, United States
Alaska Oncology & Hematology, LLC
Anchorage, Alaska, United States
Providence Alaska Medical Center
Anchorage, Alaska, United States
Providence Cancer Center
Anchorage, Alaska, United States
Banner Pediatric Specialists Hematology/Oncology Clinic
Mesa, Arizona, United States
Cardon Children's Medical Center.
Mesa, Arizona, United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Children's Hospital Of Los Angeles - University Of Southern California School Of Medicine
Los Angeles, California, United States
Kaiser Permanente - Oakland Medical Center
Oakland, California, United States
Kaiser Permanente - Oakland
Oakland, California, United States
Children's Hospital of Orange County
Orange, California, United States
Kaiser Permanente - Roseville
Roseville, California, United States
UCSD/ Rady Children's Hospital
San Diego, California, United States
Kaiser Permanente - Santa Clara
Santa Clara, California, United States
c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut, United States
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut, United States
Yale New-Haven Hospital & Smilow Cancer Center
New Haven, Connecticut, United States
Yale University
New Haven, Connecticut, United States
Yale Medical Group
Trumbull, Connecticut, United States
Nemours - A.I. duPont Hospital for Children
Wilmington, Delaware, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
JDCH pediatric Oncology and Hematology
Hollywood, Florida, United States
Joe Dimaggio Children's Hospital
Hollywood, Florida, United States
Memorial Regional Hospital
Hollywood, Florida, United States
Nemours Children's Clinic
Jacksonville, Florida, United States
Baptist Medical Center/Wolfson Children's Hospital
Jacksonville, Florida, United States
Blood and Marrow Transplant Center
Orlando, Florida, United States
Cancer Institute of Florida
Orlando, Florida, United States
Florida Hospital Cancer Institute
Orlando, Florida, United States
Nemours Children's Hospital
Orlando, Florida, United States
Memorial Cancer Institute at Memorial Hospital West
Pembroke Pines, Florida, United States
Memorial Hospital West
Pembroke Pines, Florida, United States
Johns Hopkins All Children's Hospital IDS Pharmacy
St. Petersburg, Florida, United States
Johns Hopkins All Children's Hospital
St. Petersburg, Florida, United States
Johns Hopkins All Children's Outpatient Care Pediatric Hematology/Oncology Department
St. Petersburg, Florida, United States
H.Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Children's Healthcare of Atlanta at Egleston
Atlanta, Georgia, United States
The Blood & Marrow Transplant Group Of Georgia
Atlanta, Georgia, United States
Children's Healthcare of Atlanta at Scottish Rite
Atlanta, Georgia, United States
Northside Hospital
Atlanta, Georgia, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Investigational Drugs Service Pharmacy, Attn. Judy Pi, PharmD, Ami Patel, PharmD
Chicago, Illinois, United States
The University of Chicago Medical Center
Chicago, Illinois, United States
The University of Chicago
Chicago, Illinois, United States
University of Chicago Medical Center
Chicago, Illinois, United States
Cardinal Bernardin Cancer Center/Loyola University Medical Center
Maywood, Illinois, United States
Loyola University Chicago, performing research at Loyola University Medical Center
Maywood, Illinois, United States
Loyola University Medical Center
Maywood, Illinois, United States
Indiana University Riley Hospital for Children
Indianapolis, Indiana, United States
IU Health Pharmacy
Indianapolis, Indiana, United States
Indiana Blood and Marrow Transplantation - Administrative Offices
Indianapolis, Indiana, United States
Indiana Blood and Marrow Transplantation
Indianapolis, Indiana, United States
St.Francis Hospital
Indianapolis, Indiana, United States
University of Kansas Hospital
Kansas City, Kansas, United States
The University of Kansas Cancer Center and Medical Pavilion
Westwood, Kansas, United States
The University of Kansas Cancer Center and Medical Pavillion
Westwood, Kansas, United States
University of Kansas Cancer Center
Westwood, Kansas, United States
UK Healthcare Markey Cancer Center
Lexington, Kentucky, United States
Johns Hopkins University IDS Pharmacy
Baltimore, Maryland, United States
Johns Hopkins University
Baltimore, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Mayo Clinic
Rochester, Minnesota, United States
The West Clinic, P.C. dba West Cancer Center
Southaven, Mississippi, United States
Siteman Cancer Center - West County
Creve Coeur, Missouri, United States
Children's Mercy Hospital
Kansas City, Missouri, United States
Barnes-Jewish Hospital
St Louis, Missouri, United States
Washington University Infusion Center Pharmacy
St Louis, Missouri, United States
Washington University School of Medicine, Siteman Cancer Center
St Louis, Missouri, United States
Washington University School of Medicine
St Louis, Missouri, United States
Siteman Cancer Center - South County
St Louis, Missouri, United States
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
North Shore Hematology Oncology Associates, P.C.
East Setauket, New York, United States
Weill Cornell Medical College - New York-Presbyterian Hospital
New York, New York, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Weill Cornell Medical College - New York-Presbyterian Hospital
New York, New York, United States
University of Rochester Cancer Center Pharmacy
Rochester, New York, United States
University of Rochester Medical Center
Rochester, New York, United States
Brody School of Medicine at ECU
Greenville, North Carolina, United States
Vidant Medical Center
Greenville, North Carolina, United States
University Hospitals of Cleveland Rainbow Babies & Children's Hospital
Cleveland, Ohio, United States
Nationwide Children's Hospital
Columbus, Ohio, United States
Geisinger Medical Center
Danville, Pennsylvania, United States
Milton Hershey Medical Center
Hershey, Pennsylvania, United States
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Thomas Jefferson University (Tju) - Jefferson University Physicians (Jup)
Philadelphia, Pennsylvania, United States
Thomas Jefferson University, Investigative Drug Service
Philadelphia, Pennsylvania, United States
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office (Clinical)
Philadelphia, Pennsylvania, United States
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office (Regulatory)
Philadelphia, Pennsylvania, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
St. Christopher's Hospital for Children
Philadelphia, Pennsylvania, United States
Allegheny Health Network, Cancer Institute, West Penn Hospital
Pittsburgh, Pennsylvania, United States
The West Clinic, P.C. dba West Cancer Center
Germantown, Tennessee, United States
East Tennessee Children's Hospital
Knoxville, Tennessee, United States
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
Baptist Memorial Hospital
Memphis, Tennessee, United States
The West Clinic, P.C. dba West Cancer Center
Memphis, Tennessee, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
Sarah Cannon Center for Blood Cancer
Nashville, Tennessee, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
Tennessee Oncology - Nashville
Nashville, Tennessee, United States
Tennessee Oncology, PLLC
Nashville, Tennessee, United States
The Children's Hospital at TriStar Centennial
Nashville, Tennessee, United States
TriStar Centennial Medical Center/Sarah Cannon Cener for Blood Cancer
Nashville, Tennessee, United States
TriStar Centennial Medical Center
Nashville, Tennessee, United States
TriStar Medical Group Children's Specialist
Nashville, Tennessee, United States
VA Tennessee Valley Healthcare System - Nashville Campus
Nashville, Tennessee, United States
Monroe Carell Jr. Children's Hospital at Vanderbilt
Nashville, Tennessee, United States
Vanderbilt University Medical Center - The Vanderbilt Clinic
Nashville, Tennessee, United States
Children's Blood and Cancer Center
Austin, Texas, United States
Dell Children's Medical Center of Central Texas
Austin, Texas, United States
Dell Children's Medical Center
Austin, Texas, United States
El Paso Children's Hospital
El Paso, Texas, United States
Texas Tech University Health Sciences Center
El Paso, Texas, United States
Cook Children's Hematology/Oncology Center
Fort Worth, Texas, United States
Cook Children's Medical Center
Fort Worth, Texas, United States
Cook Children's Hematology/Oncology Center - Grapevine
Grapevine, Texas, United States
Houston Methodist Hospital
Houston, Texas, United States
Texas Children's Hospital Attn: Investigational Pharmacy Services
Houston, Texas, United States
Texas Children's Hospital
Houston, Texas, United States
Houston Methodist Cancer Center
Houston, Texas, United States
Huntsman Cancer Hospital
Salt Lake City, Utah, United States
Huntsman Cancer Institute-University of Utah
Salt Lake City, Utah, United States
Primary Children's Hospital
Salt Lake City, Utah, United States
Cancer Center IDS Pharmacy Attn: Lauren Benusa, Pharm D.
Charlottesville, Virginia, United States
Emily Couric Clinical Cancer Center
Charlottesville, Virginia, United States
UVA Health System
Charlottesville, Virginia, United States
Virginia Oncology Associates
Hampton, Virginia, United States
Children's Hospital of the King's Daughters
Norfolk, Virginia, United States
Virginia Oncology Associates
Virginia Beach, Virginia, United States
Swedish Medical Center First Hill, IDS Pharmacy
Seattle, Washington, United States
Seattle Children's IDS Pharmacy - Attn. Laura Winter
Seattle, Washington, United States
Seattle Children's
Seattle, Washington, United States
Lisa Nakatsu, RPh
Seattle, Washington, United States
Fox Valley Hematology & Oncology, SC
Appleton, Wisconsin, United States
Aurora BayCare Medical Center
Green Bay, Wisconsin, United States
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Fox Valley Hematology & Oncology, SC
Oshkosh, Wisconsin, United States
Aurora Health Care, Aurora Cancer Care
Wauwatosa, Wisconsin, United States
Aurora Health Care, Aurora Cancer Care
West Allis, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wang ES, Aplenc R, Chirnomas D, Dugan M, Fazal S, Iyer S, Lin TL, Nand S, Pierce KJ, Shami PJ, Vermette JJ, Abboud CN. Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid leukemia. Leuk Lymphoma. 2020 Aug;61(8):1965-1973. doi: 10.1080/10428194.2020.1742897. Epub 2020 May 20.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B1761026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.